210 related articles for article (PubMed ID: 30301398)
21. Insulin glargine added to therapy with oral antidiabetic agents improves glycemic control and reduces long-term complications in patients with type 2 diabetes - a simulation with the Diabetes Mellitus Model (DMM).
Janka HU; Hessel F; Walzer S; Mã Ller E
Int J Clin Pharmacol Ther; 2007 Dec; 45(12):623-30. PubMed ID: 18184530
[TBL] [Abstract][Full Text] [Related]
22. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
23. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
Ilag LL; Kerr L; Malone JK; Tan MH
Clin Ther; 2007 Jun; 29(6 Pt 1):1254-70. PubMed ID: 18036388
[TBL] [Abstract][Full Text] [Related]
24. Optimizing Insulin Therapy: Basal Insulin and Beyond.
Aroda V; Johnson EL; Novak L; Skolnik N
J Fam Pract; 2018 Oct; 67(10 Suppl):. PubMed ID: 30423012
[TBL] [Abstract][Full Text] [Related]
25. Drug treatments for managing cystic fibrosis-related diabetes.
Onady GM; Stolfi A
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD004730. PubMed ID: 33075159
[TBL] [Abstract][Full Text] [Related]
26. The effect of early insulin therapy on pancreatic β-cell function and long-term glycemic control in newly diagnosed type 2 diabetic patients.
Chon S; Oh S; Kim SW; Kim JW; Kim YS; Woo JT
Korean J Intern Med; 2010 Sep; 25(3):273-81. PubMed ID: 20830224
[TBL] [Abstract][Full Text] [Related]
27. Insulin management of type 2 diabetes mellitus.
Petznick A
Am Fam Physician; 2011 Jul; 84(2):183-90. PubMed ID: 21766768
[TBL] [Abstract][Full Text] [Related]
28. Managing type 2 diabetes: going beyond glycemic control.
Stolar MW; Hoogwerf BJ; Gorshow SM; Boyle PJ; Wales DO
J Manag Care Pharm; 2008 Jun; 14(5 Suppl B):s2-19. PubMed ID: 18597582
[TBL] [Abstract][Full Text] [Related]
29. Insulin therapy in patients with type 2 diabetes and high insulin resistance is associated with increased risk of complications and mortality.
Mendez CE; Walker RJ; Eiler CR; Mishriky BM; Egede LE
Postgrad Med; 2019 Aug; 131(6):376-382. PubMed ID: 31311382
[No Abstract] [Full Text] [Related]
30. [Glycemic control and cardiovascular benefit: What do we know today?].
Hanefeld M; Schönauer M; Forst T
Dtsch Med Wochenschr; 2010 Feb; 135(7):301-7. PubMed ID: 20146161
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the long-term cost-effectiveness of IDegLira versus liraglutide added to basal insulin for patients with type 2 diabetes failing to achieve glycemic control on basal insulin in the USA.
Hunt B; Mocarski M; Valentine WJ; Langer J
J Med Econ; 2017 Jul; 20(7):663-670. PubMed ID: 28294641
[TBL] [Abstract][Full Text] [Related]
32. Intensive glucose control in the management of diabetes mellitus and inpatient hyperglycemia.
Shogbon AO; Levy SB
Am J Health Syst Pharm; 2010 May; 67(10):798-805. PubMed ID: 20479101
[TBL] [Abstract][Full Text] [Related]
33. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
34. Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus.
Genuth S
Ann Intern Med; 1996 Jan; 124(1 Pt 2):104-9. PubMed ID: 8554200
[TBL] [Abstract][Full Text] [Related]
35. Risk Factors for Nocturnal Hypoglycemia in Insulin-treated Patients With Type 2 Diabetes: A Secondary Analysis of Observational Data Derived From an Integrated Clinical Trial Database.
Bae JP; Duan R; Fu H; Hoogwerf BJ
Clin Ther; 2017 Sep; 39(9):1790-1798.e7. PubMed ID: 28781218
[TBL] [Abstract][Full Text] [Related]
36. Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis.
Kramer CK; Zinman B; Retnakaran R
Lancet Diabetes Endocrinol; 2013 Sep; 1(1):28-34. PubMed ID: 24622264
[TBL] [Abstract][Full Text] [Related]
37. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS
Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
[TBL] [Abstract][Full Text] [Related]
38. Intensive insulin regimens: evidence for benefit.
Bretzel RG
Int J Obes Relat Metab Disord; 2004 Sep; 28 Suppl 2():S8-13. PubMed ID: 15306832
[TBL] [Abstract][Full Text] [Related]
39. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review.
DeWitt DE; Hirsch IB
JAMA; 2003 May; 289(17):2254-64. PubMed ID: 12734137
[TBL] [Abstract][Full Text] [Related]
40. Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study.
Kawamori R; Node K; Hanafusa T; Atsumi Y; Naito Y; Oka Y
Cardiovasc Diabetol; 2013 Sep; 12():131. PubMed ID: 24011395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
